Founder Secondary Sales: The Closing Checklist Nobody Gives You

Founder Secondary Sales: The Closing Checklist Nobody Gives You

This post uses hypothetical scenarios for illustrative purposes only. It does not describe any actual client, transaction, or representation, and is not legal advice.

A founder decides to sell a portion of their equity in a private company. Maybe it’s a late-stage company with a clear path to liquidity, or maybe it’s a growth-stage company where a secondary buyer has approached with a reasonable offer. The founder expects the process to resemble a stock sale: agree on price, sign a purchase agreement, wire the funds, update the cap table. What actually happens is a procedural gauntlet that touches corporate governance, securities law, stockholder agreements, tax structuring, and transfer-agent mechanics, often simultaneously, with deadlines that interact in ways the parties don’t anticipate until they’re already in motion.

The reason secondary sales are harder than founders expect isn’t that any single step is especially complex. It’s that the steps are interdependent, and missing one early step can cascade into delays that threaten the entire transaction. What follows is a structured view of what a closing checklist for a private-company secondary transfer actually has to cover.

ROFR and Co-Sale Timeline Management

Nearly every venture-backed company’s investor agreements include a right of first refusal (ROFR) and a co-sale right (sometimes called tag-along). These provisions require the selling founder to notify the company and, through the company, the other stockholders of the proposed sale terms. The ROFR holders then have a specified period, typically fifteen to thirty days, to elect to purchase the shares on the same terms. If they decline, the co-sale holders may have a separate window to elect to participate in the sale on a pro rata basis.

The timeline management here is more intricate than it appears. First, the ROFR notice must contain specific information: the identity of the proposed purchaser, the price per share, the number of shares, and any other material terms. An incomplete notice can restart the clock. Second, the ROFR period and the co-sale period may run sequentially rather than concurrently, meaning the total waiting period can be forty-five to sixty days before the founder is free to proceed. Third, if any ROFR holder elects to purchase, the transaction’s economics change: the founder may be selling fewer shares to the secondary buyer and more shares to existing investors, which affects the purchase agreement, the funds flow, and potentially the securities-law analysis.

The closing checklist needs to capture: the date the ROFR notice was delivered, the method of delivery (and whether it complies with the notice provisions in the investors’ rights agreement or right of first refusal agreement), the expiration date of the ROFR period, the expiration date of the co-sale period, and the responses received from each holder. A spreadsheet tracking each holder’s election status, with dates, is not optional; it’s a closing deliverable.

Stock-Ledger Reconciliation

Before any shares can transfer, the company’s stock ledger must accurately reflect the seller’s holdings. This sounds like it should be a given, but in practice, stock ledgers for private companies are frequently out of date, incomplete, or maintained across multiple systems that don’t agree with each other.

A hypothetical scenario illustrates the problem. A founder holds shares that were originally issued as restricted stock, subject to vesting. Some shares have vested, some have not. The company has gone through two financing rounds, each of which involved a charter amendment and potentially a stock split or recapitalization. The founder exercised some stock options two years ago. The stock ledger should reflect the original restricted stock grant (net of any unvested shares that were repurchased), the shares issued on option exercise, and the correct post-split share counts for each lot.

If the stock ledger doesn’t reconcile, the secondary sale cannot close cleanly. The transfer agent (or the company, if it maintains its own ledger) will not process a transfer of shares that don’t appear on the ledger in the seller’s name, in the correct quantity, of the correct class and series. The closing checklist should include a pre-closing ledger reconciliation, signed off by the company’s corporate secretary or outside counsel, and a post-closing ledger update reflecting the transfer.

Securities-Law Pathway

The securities-law analysis for a secondary sale is more nuanced than many founders realize, and it’s an area where imprecise advice can create real liability. The key point is that a resale of restricted securities by a stockholder is a separate transaction from the company’s original issuance, and the exemption analysis runs differently.

On the federal side, the seller needs a resale exemption. Rule 144 under the Securities Act provides the most common pathway for resales of restricted securities, but its conditions (holding period, current public information, volume limitations for affiliates) must be independently satisfied. For private companies, the “current public information” requirement under Rule 144 is often unavailable, which means sellers frequently rely on Section 4(a)(1) (the ordinary trading exemption) or, for transactions involving sophisticated purchasers, Section 4(a)(7) or the so-called “Section 4(a)(1-1/2)” doctrine.

A critical distinction: the purchaser’s status as an accredited investor is relevant to the analysis, but accredited-investor status alone does not establish the availability of a seller-side exemption. The exemption analysis examines the seller’s circumstances (holding period, affiliate status, manner of sale) separately from the purchaser’s qualifications. A closing checklist that says “confirm purchaser is accredited” and treats the securities-law workstream as complete has conflated two distinct inquiries.

On the state level, the analysis varies by jurisdiction. Some states provide exemptions for isolated transactions, for sales to institutional buyers, or for transactions that qualify under a federal exemption. Others require a separate filing or notice. The closing checklist should identify the applicable state jurisdictions (seller’s state, purchaser’s state, company’s state of incorporation, and potentially the company’s principal place of business) and confirm the available exemption in each.

Escrow and Funds-Flow Controls

Secondary transactions often involve an escrow arrangement, particularly when the purchase price is subject to any post-closing adjustment or when the seller’s representations include a survival period with an indemnification tail. Even when a full escrow isn’t required, the funds-flow mechanics need careful documentation.

The closing checklist should address: the identity of the escrow agent (if any), the escrow agreement’s release conditions, the wire instructions for all parties (verified directly with the receiving banks, not through email alone, to mitigate wire-fraud risk), any tax withholding obligations (particularly relevant if the seller is a non-US person or if the company has made a Section 83(b) election that affects the tax basis of the shares), and the sequence of fund movements. In a hypothetical transaction where the purchase price is $2 million, a simultaneous sign-and-close with funds wired to the seller’s account upon receipt of executed documents, the funds-flow memo needs to specify who confirms receipt of each deliverable before releasing the wire instruction.

The Board and Committee Conflict Workstream

In many secondary transactions, one or more members of the company’s board of directors may have a conflict of interest. The purchasing fund may have a board seat. The selling founder may be a director. The company may need to approve the transfer under its bylaws or charter, requiring board action by directors who are not interested in the transaction.

Delaware law provides well-established frameworks for managing these conflicts, including the protections recognized in cases like Kahn v. M&F Worldwide Corp. (MFW) for controller transactions and the cleansing effect of disinterested director or stockholder approval under Corwin v. KKR Financial Holdings LLC. While those cases arise in different transaction contexts, the underlying principle applies: the corporate governance process for approving a secondary transfer should be structured to demonstrate that disinterested decision-makers approved the transaction on terms they independently evaluated.

The closing checklist should identify every conflicted director, document the basis for the conflict, specify the approval mechanism (disinterested director approval, independent committee, or stockholder approval), and ensure the board or committee consent recites the relevant findings. If the company has a conflicts policy in its corporate governance documents, compliance with that policy should be confirmed and documented.

Putting the Checklist Together

A complete secondary-sale closing checklist, then, covers at minimum these workstreams: ROFR and co-sale notice and election tracking, stock-ledger reconciliation (pre- and post-closing), securities-law exemption analysis (federal resale exemption, state exemptions, and purchaser eligibility as a separate inquiry), escrow and funds-flow documentation, board or committee approval with conflict management, and the purchase agreement itself with representations, covenants, and conditions precedent that tie back to each of these workstreams.

The checklist is also a timeline. ROFR notices must go out before the purchase agreement can be finalized (because ROFR elections may change the share count). The securities-law opinion (if one is required) depends on the final transaction terms. The board consent must be adopted before closing but after the terms are known. The funds-flow memo requires finalized wire instructions from all parties. Each of these dependencies creates a critical path, and the checklist’s job is to make that critical path visible so that no workstream stalls waiting on a predecessor that nobody remembered to start.

Founders who approach a secondary sale expecting a simple stock transfer learn quickly that the procedural overhead is substantial. The good news is that it’s manageable when it’s mapped in advance. The bad news is that it’s rarely mapped in advance.

If you are considering or negotiating a secondary sale of private-company stock and want to ensure the closing process is structured correctly from the start, feel free to reach out to our firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.

Legal Disclaimer

The information provided in this article is for general informational purposes only and should not be construed as legal or tax advice. The content presented is not intended to be a substitute for professional legal, tax, or financial advice, nor should it be relied upon as such. Readers are encouraged to consult with their own attorney, CPA, and tax advisors to obtain specific guidance and advice tailored to their individual circumstances. No responsibility is assumed for any inaccuracies or errors in the information contained herein, and John Montague and Montague Law expressly disclaim any liability for any actions taken or not taken based on the information provided in this article.

Contact Info

Address: 5472 First Coast Hwy #14
Fernandina Beach, FL 32034

Phone: 904-234-5653

More Articles